Abstracts tagged "juvenile idiopathic arthritis (JIA) and outcome measures"

Abstract Number: 2859 • 2017 ACR/ARHP Annual Meeting
Development of New Juvenile Arthritis Disease Activity Score Cut-Offs for Oligoarthritis and RF-Negative Polyarthritis from a Large Multinational Cohort of Children with Juvenile Idiopathic Arthritis
Alessandro Consolaro^1,2, Pieter Van Dijkhuizen¹, Graciela Espada³, Boriana Varbanova⁴, Sheila Oliveira⁵, Paivi Miettunen⁴, Gaëlle Chédeville⁵, Michaël Hofer⁵, Pavla Dolezalová⁵, Ivan Foeldvari⁵, Gerd Horneff⁵, Anne Estmann⁵, Chris Pruunsild⁵, Rosa Merino⁵, Inmaculada Calvo Penades⁵, Pablo Mesa del Castillo⁵, Pekka Lahdenne⁵, Maka Ioseliani⁵, Maria Trachana⁵, Olga Vougiouka⁵, Miroslav Harjacek⁵, Ilonka Orban⁵, Tamás Constantin⁵, Nahid Shafaie⁵, Violeta Vladislava Panaviene⁵, Marite Rygg⁵, Elzbieta Smolewska⁵, Jose Antonio Melo Gomes⁵, Jelena Vojinovic⁵, Ekaterina Alexeeva⁵, Tadej Avcin⁵, Veronika Vargova⁵, Nuray Aktay Ayaz⁶, Ozgur Kasapcopur⁵, Yaryna Boyko⁵, Sarah Ringold⁵, Mariangela Rinaldi⁵, Marco Garrone⁵, Nicolino Ruperto⁷ and Angelo Ravelli^8,9, ¹Pediatria II, Reumatologia, Istituto Giannina Gaslini, Genoa, Italy, ²University of Genova, GENOA, Italy, ³Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Genova, Italy, ⁴Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, GENOA, Italy, ⁵Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Genoa, Italy, ⁶Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Gernoa, Italy, ⁷Istituto Giannina Gaslini, Genoa, Italy, ⁸University of Genova, IRCCS Istituto Giannina Gaslini, Genova, Italy, ⁹University of Genova, Genova, Italy
Background/Purpose: The measurement of the level of disease activity plays a pivotal role in the care of patients with juvenile idiopathic arthritis (JIA). To serve…
Abstract Number: 59 • 2017 Pediatric Rheumatology Symposium
Six Minute Walk Test in Children with Juvenile Idiopathic Arthritis
Dax G. Rumsey^1,2, Cara Kaup², Michelle Roy², Lyne Bourassa³, Elham Khodayari Moez⁴, Olaf Verschuren⁵ and Lesley Pritchard-Wiart^2,6, ¹Paediatrics, University of Alberta, Edmonton, AB, Canada, ²Glenrose Rehabilitation Hospital Edmonton, Edmonton, AB, Canada, ³Physical Therapy, University of Alberta, Edmonton, Netherlands, ⁴School of Public Health, University of Alberta, Edmonton, AB, Canada, ⁵Brain Center Rudolf Magnus and Center of Excellence for Rehabilitation Medicine, University Medical Centre Utrecht, Utrecht, Netherlands, ⁶Physical Therapy, University of Alberta, Edmonton, AB, Canada
Background/Purpose: The 6-minute walk test (6MWT) is a widely used measure of functional exercise capacity. It has not, however, been routinely used in pediatric rheumatology…
Abstract Number: 2447 • 2015 ACR/ARHP Annual Meeting
The Juvenile Arthritis Disease Activity Score Remains the Disease Activity Marker of Choice for Adults with Polyarticular Juvenile Idiopathic Arthritis
Qiong Wu¹, Nicola Ambrose^1,2,3, Debajit Sen^1,2,3, Maria J. Leandro⁴, Charlotte Wing², Nicola Daly², Kate Webb^1,2, Corinne Fisher^1,2, Linda Suffield¹, Francesca Josephs¹, Clarissa Pilkington³, Despina Eleftheriou^1,3, Muthana Al-Obaidi³, Sandrine Compeyrot-Lacassagne³, Lucy R Wedderburn^1,3 and Yiannis Ioannou^1,2,3, ¹Arthritis Research UK Centre for Adolescent Rheumatology, University College London, London, United Kingdom, ²Adolescent Rheumatology Department, University College London Hospital NHS Trust, London, United Kingdom, ³Paediatric Rheumatology Department, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom, ⁴Centre for Rheumatology and Bloomsbury Rheumatology Unit, University College London, London, United Kingdom
Background/Purpose: A considerable proportion of children with polyarticular juvenile idiopathic arthritis (polyJIA) continue to experience active disease into adulthood. There is no validated disease activity…
Abstract Number: 1158 • 2012 ACR/ARHP Annual Meeting
Development of Cut-off Values for High Disease Activity in Juvenile Idiopathic Arthritis Based On the Juvenile Arthritis Disease Activity Score
Alessandro Consolaro¹, Stefano Lanni¹, Sara Verazza¹, Maria C. Gallo¹, Marta Bertamino¹, Giulia C. Varnier¹, Serena Calandra², Nicolino Ruperto³, Alberto Martini⁴ and Angelo Ravelli⁵, ¹Pediatria II, Istituto Giannina Gaslini, Genova, Italy, ²University of Genova, Genova, Italy, ³Paediatric Rheumatology International Trials Organisation [PRINTO], Genova, Italy, ⁴Pediatric Rheumatology Collaborative Study Group [PRSCG], Cincinnati, OH, ⁵Paediatric Rheumatology International Trials Organization (PRINTO), Istituto Giannina Gaslini, Genova, Italy
Background/Purpose: In the last decade, there have been major advances in the management of juvenile idiopathic arthritis (JIA), including the shift towards early aggressive interventions…
Abstract Number: 1154 • 2012 ACR/ARHP Annual Meeting
Impact of FokI VDR and TNFalpha–308 Polymorphism On Disease Severity and Long Term Outcome in JIA Patients On Anti-TNF Treatment
Jelena Vojinovic¹, Jelena Basic², Gordana Susic³, Dragana Lazarevic⁴ and Nemanja Damjanov⁵, ¹Dept Pediatric Rheumatology, Clinical Center, School of Medicine University of Nis, Nis, Serbia, ²Institute of Biochemistry, School of Medicine University of Nis, Dr, Nis, Serbia, ³Istituto Giannina Gaslini, Genoa, Italy, ⁴Dept Pediatric Rheumatology, Clinical Center, School of Medicine University of Nis, Dr, Nis, Serbia, ⁵Institute for Rheumatology, University of Belgrade, Prof, Belgrade, Serbia
Background/Purpose: Genetic contribution of SNP (single nucleotide polymorphism) of TNFα–308 promoter and FoxI for VDR (vitamin D receptor) polymorphism on disease severity and outcome in…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].